Thixotropic polyurethane compositions as sealants for membrane separatory devices

Claim 2

A folded membrane separatory device capable of use in a biomedical application comprising: (a) a case: (b) a membrane located within said case and comprising a plurality of folds which form a series of adjacent channels between said folds, the edge portions of each fold being sealed with a polyurethane composition comprising the cured composition of a curable nonflowing thixotropic polyurethane composition comprising: (1) about 60% to about 20% of a prepolymer comprising the reaction product of a polyol having a hydroxyl functionality of at least 2 with at least one mole per hydroxy group of said polyol of an organic diisocyanate; and (2) about 40% to about 80% of a crosslinking agent comprising about 75% to about 99% of a polyether polyol having a hydroxyl functionality of at least 2 and the remaining amount of cross-linking agent being a primary amine-terminated polyether having an amine functionality of at least 2.

Claim 3

The composition of claim 1 wherein said polyol in the prepolymer is selected from the group consisting of castor oil, a polyol ester of a hydroxy carboxylic acid having at least 12 carbon atoms, a polyether polyol having a molecular weight of from about 200 to 2000 and mixtures thereof.

Claim 4

The composition of claim 1 wherein said diisocyanate is selected from the group consisting of arylene diisocyanates and mixtures thereof with aliphatic diisocyanates.

Claim 5

The composition of claim 1 wherein said polyether polyol in the crosslinking agent has a molecular weight of from about 1000 to 4000.

Claim 6

The composition of claim 1 wherein said primary amine-terminated polyether is a polyoxypropylene glycol polyamine having a molecular weight of from about 200 to 500.

Claim 7

The composition of claim 1 wherein said crosslinking agent further includes a hydroxyl-containing tertiary amine.

Claim 8

A folded membrane separatory device capable of use in a biomedical application comprising: (a) a case comprised of a polymeric material selected from the group consisting of polystyrene, styreneacrylonitrile copolymers and polycarbonates; (b) a membrane located within said case having a plurality of folds and a series of adjacent channels formed between said folds, the edge portions of each fold being sealed with the cured polyurethane composition of a curable nonflowing thixotropic polyurethane composition comprising: (1) about 60% to about 20% of a prepolymer comprising the reaction product of a polyol having a hydroxyl functionality of at least 2 and selected from the group consisting of castor oil, a polyol ester of a hydroxy carboxylic acid having at least 12 carbon atoms, a polyether polyol having a molecular weight of from about 200 to 2000 and mixtures thereof with at least one mole per hydroxy group of said polyol of an arylene diisocyanate and; (2) about 40% to about 80% of a crosslinking agent comprising (1) about 75% to about 99% of a polyether polyol having a hydroxyl functionality of at least 2 and a molecular weight of from about 1000 to 4000, above about 40% of the hydroxyl groups of said polyol being terminal and primary; (2) about 1% to about 10% of a polyoxypropylene glycol polyamine having a molecular weight of from about 200 to 500 and an amine functionality of at least 2; and (3) up to about 10% of N,N,N 1 ,N 1 ,-tetrakis(2-hydroxypropyl)ethylene diamine or diisopropanol amine.

Claim 9

A folded membrane separatory device capable of use in a biomedical application comprising: (a) a case comprised of a polymeric material selected from the group consisting of polystyrene, styreneacrylonitrile copolymers and polycarbonates; (b) a membrane located within said case having a plurality of folds and a series of adjacent channels formed between said folds, the edge portions of each fold being sealed with the cured polyurethane composition of a curable nonflowing thixotropic polyurethane composition comprising: (1) about 60% to about 20% of a prepolymer comprising the reaction product of a polyol having a hydroxyl functionality of at least 2 and selected from the group consisting of castor oil, a polyol ester of a hydroxy carboxylic acid having at least 12 carbon atoms, a polyether polyol having a molecular weight of from about 200 to 2000 and mixtures thereof with at least one mole per hydroxy group of said polyol of an arylene diisocyanate and; (2) about 40% to about 80% of a crosslinking agent comprising (1) about 75% to about 99% of a polyether polyol having a hydroxyl functionality of at least 2 and a molecular weight of from about 1000 to 4000, above about 40% of the hydroxyl groups of said polyol being terminal and primary; (2) about 1% to about 10% of a polyoxypropylene glycol polyamine having a molecular weight of from about 200 to 500 and an amine functionality of at least 2; and (3) up to about 10% of N,N,N 1 ,N 1 ,-tetrakis(2-hydroxypropyl)ethylene diamine or diisopropanol amine.

Claim 10

The composition of claim 7 wherein said polyol ester is castor oil.

Claim 11

The composition of claim 7 wherein said polyether polyol in the prepolymer is a polyether diol having a molecular weight of about 400.

Claim 12

The composition of claim 7 wherein said polyether polyol in the crosslinking agent is a polyoxypropylenetriol having a molecular weight of about 3000 and being end-capped with ethylene oxide to provide approximately 60% primary hydroxyl groups.

Claim 13

The composition of claim 7 wherein said crosslinking agent further includes a polyether tetrol.

Claim 14

A folded membrane artificial kidney comprising: (a) a case comprised of a polymeric material selected from the group consisting of polystyrene, styreneacrylonitrile copolymers and polycarbonates; (b) a membrane located within said case having a plurality of folds and a series of adjacent channels formed between said folds, the edge portions of each fold being sealed with the polyurethane composition of a curable nonflowing thixotropic polyurethane composition comprising: (1) about 60% to about 20% of a prepolymer comprising the reaction product of a polyol consisting of a mixture of castor oil and a polyether diol having a molecular weight of about 400 with at least one mole per hydroxy group of said polyol of an arylene diisocyanate; and (2) about 40% to about 80% of a crosslinking agent comprising a mixture of (1) about 75% to about 99% of a polyoxypropylene triol having a molecular weight of about 3000 and being end-capped with ethylene oxide to provide above about 40% primary hydroxyl groups or a polyether tetrol; (2) about 1% to about 10% of a polyoxypropylene glycol polyamine having a molecular weight of about 230; and (3) up to about 10% of N,N,N 1 ,N 1 ,-tetrakis(2-hydroxypropyl)ethylene diamine or diisopropanol amine.

Claim 15

A folded membrane artificial kidney comprising: (a) a case comprised of a polymeric material selected from the group consisting of polystyrene, styreneacrylonitrile copolymers and polycarbonates; (b) a membrane located within said case having a plurality of folds and a series of adjacent channels formed between said folds, the edge portions of each fold being sealed with the polyurethane composition of a curable nonflowing thixotropic polyurethane composition comprising: (1) about 60% to about 20% of a prepolymer comprising the reaction product of a polyol consisting of a mixture of castor oil and a polyether diol having a molecular weight of about 400 with at least one mole per hydroxy group of said polyol of an arylene diisocyanate; and (2) about 40% to about 80% of a crosslinking agent comprising a mixture of (1) about 75% to about 99% of a polyoxypropylene triol having a molecular weight of about 3000 and being end-capped with ethylene oxide to provide above about 40% primary hydroxyl groups or a polyether tetrol; (2) about 1% to about 10% of a polyoxypropylene glycol polyamine having a molecular weight of about 230; and (3) up to about 10% of N,N,N 1 ,N 1 ,-tetrakis(2-hydroxypropyl)ethylene diamine or diisopropanol amine.